RGEN vs BAX

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Sep 11, 2026

RGEN

45.4
AI Score
VS
RGEN Wins

BAX

35.1
AI Score

Investment Advisor Scores

RGEN

45score
Recommendation
HOLD

BAX

35score
Recommendation
SELL

AI Analyst Insights

Detailed Metrics Comparison

Metric RGEN BAX Winner
Forward P/E 61.3497 12.1507 BAX
PEG Ratio 1.6799 36.6767 RGEN
Revenue Growth 11.9% 5.3% RGEN
Earnings Growth -65.9% 36.8% BAX
Tradestie Score 45.4/100 35.1/100 RGEN
Profit Margin 5.3% -9.3% RGEN
Beta 1.00 1.00 Tie
AI Recommendation HOLD SELL RGEN

Relative Price Performance (Last 90 Days)

RGEN 1M: -0.3% · 3M: +23.9% BAX 1M: -11.7% · 3M: +16.2%

Current Technical Phase

RGEN

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 48

RSI (14): 47.7 · Price: $165.18

BAX

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 35

RSI (14): 35.1 · Price: $23.80

Fundamentals Snapshot

Metric RGEN BAX
Market Cap
Forward P/E 62.3 11.7
Trailing P/E 228.7
Revenue (TTM)
Revenue Growth 0.1% 0.1%
Gross Margin 0.5% 0.3%
Operating Margin 0.1% 0.1%
EPS 0.72 -1.86
Dividend Yield 0.01%

Frequently Asked Questions

Based on our detailed analysis, RGEN is currently the stronger investment candidate based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.